News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
January 26, 2021
2021

AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%

Read article
News
January 21, 2021
2021

AbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for Residents

Read article
News
January 19, 2021
2021

AbCellera Granted US Patent Covering its Trianni Mouse® Technology

Read article
News
January 14, 2021
2021

adMare Launches Abdera with AbCellera as a Founding Partner

Read article
News
December 21, 2020
2020

AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico

Read article
News
December 16, 2020
2020

AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares

Read article
News
December 11, 2020
2020

AbCellera Announces Pricing of Initial Public Offering

Read article
News
November 20, 2020
2020

AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19

Read article
News
November 19, 2020
2020

Peter Thiel Joins AbCellera's Board of Directors

Read article
News
November 19, 2020
2020

AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health

Read article